Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.7175 per ML under NDC 68462028169. Its NADAC has been published 118 times since Jul 3, 2024.

FDA first approved this application on May 16, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Brimonidine Tartrate and Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$2.7175per ML
High Outlier

Strength

2; 5 mg/mL; mg/mL

NDC

68462028169

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214987

FDA Approved

5/16/2024

TE Code

AB

On Market Since

5/16/2024

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 118 times since Jul 3, 2024, and over the history we have for it it has declined 75.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7175 per ML
All-time high$11.2842 (Jul 10, 2024)
All-time low$2.7175 (Sep 23, 2026)
52-week high$4.4337
52-week low$2.7175
Median price$4.9566
Average price$5.0796
Largest weekly change-37.2% (Jul 17, 2024)
Weeks tracked118
Tracking sinceJul 3, 2024

Price History

1W

0.0%

1M

-2.8%

3M

-5.7%

6M

-15.9%

1Y

-38.7%

3Y

N/A

5Y

N/A

All

-75.9%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.7175 per ML (NDC 68462028169), effective Sep 30, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 75.9%. It has been tracked across 118 weekly CMS publications since Jul 3, 2024.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Jul 3, 2024, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $2.7175 (Sep 23, 2026) to a high of $11.2842 (Jul 10, 2024), with a median of $4.9566 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE-TIMOLOL 0.2%-0.5%, is $1.9717 per ML — about 27% below BRIMONIDINE-TIMOLOL 0.2%-0.5%.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 68462028169) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.